DMAC vs GE · $157.4M cap vs P/E 44, rev $45.85B
DiaMedica Therapeutics Inc (DMAC) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
DMAC does not have a complete income-statement cache yet.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
DMAC currently screens at market cap $157.4M. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the DMAC and GE stock pages for the full models.
Not investment advice.